(R)-2-(9-(Pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl)acetonitrile, 95.0%, 5g

TERT-BUTYL 4-CYANO-3-OXOPIPERIDINE-1-CARBOXYLATE, 95.0%, 1g

z-tyr-ome, 95.0%, 5g

N-Butyl-N'-isopropyl ethylenediamine, 98.0%, 1g

7-Bromo-2-methyl-2H-indazole, 95.0%, 25g

2-(3-CHLORO-4-FLUOROPHENYL)-4,4-DIMETHYL-1,2,3,4-TETRAHYDROQUINOLINE-6-CARBOXYLIC ACID, 95.0%, 100mg

Slotted ladles ROTILABO® Flat, , 120 mm, 360 mm, 1 Piece

2-(Benzyloxy)aniline, 95.0%, 5g

Isoquinoline-8-carbonitrile, 95.0%, 1g

Hexaamminecobalt(III) Chloride>99.0%(T)500g

Infinity corrected plan phase S100x/1.25 objective. Working distance 0.18 mm

GC capillary column ROTI®Cap-1701, 60 m, 0.32 mm, 0.35 µm, 1 Piece(s)

Nickel(II) sulphate hexahydrate, min. 98%, ultra pure, 500 g, plastic packaging.